{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:54:42Z","timestamp":1795049682920,"version":"4.10.2"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274013"],"award-info":[{"award-number":["82274013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20191323"],"award-info":[{"award-number":["BK20191323"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118665","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:43:23Z","timestamp":1761047003000},"page":"118665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrated pharmacokinetic properties and tissue distribution of Corydalis saxicola Bunting total alkaloids in HFHCD-induced mice: Implications for pharmacokinetic variability in MASH treatment"],"prefix":"10.1016","volume":"192","author":[{"given":"Qiushuang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-1776","authenticated-orcid":false,"given":"Zhixia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2025.118665_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of nafld","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118665_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2025.118665_bib3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.biopha.2025.118665_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118665_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in nash drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"issue":"1.","key":"10.1016\/j.biopha.2025.118665_bib6","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"Nafld: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118665_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.biopha.2025.118665_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in nash with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118665_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118665_bib10","article-title":"The traditional uses, phytochemistry, pharmacokinetics, pharmacology, toxicity, and applications of corydalis saxicola bunting: a review","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118665_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13020-021-00468-5","article-title":"Corydalis saxicola bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through pkcepsilon\/p38 mapk\/trpv1 signaling pathway","volume":"16","author":"Xue","year":"2021","journal-title":"Chin. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118665_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021626","article-title":"Corydalis saxicola bunting: a review of its traditional uses, phytochemistry, pharmacology, and clinical applications","volume":"24","author":"Qin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2025.118665_bib13","article-title":"Corydalis saxicola bunting total alkaloids improve nafld by suppressing de novo lipogenesis through the ampk-srebp1 axis","volume":"319","author":"Guo","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118665_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202201255","article-title":"Inhibitory effects of corydalis saxicola bunting total alkaloids on macrophage pyroptosis","volume":"20","author":"Feng","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.biopha.2025.118665_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113132","article-title":"Corydalis saxicola bunting total alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic pi3k\/akt and tlr4\/nf-kappab pathways in mice","volume":"151","author":"Wu","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118665_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115024","article-title":"Intracellular spatiotemporal metabolism in connection to target engagement","volume":"200","author":"Zhang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118665_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17425255.2021.1867105","article-title":"Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy","volume":"17","author":"Bechtold","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118665_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/03602532.2023.2202359","article-title":"The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice","volume":"55","author":"Zhu","year":"2023","journal-title":"Drug Metab. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118665_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of obesity on drug metabolism and elimination in adults and children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118665_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ajkd.2003.07.019","article-title":"Hepatic drug metabolism and transport in patients with kidney disease","volume":"42","author":"Nolin","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118665_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030815","article-title":"Effects of honokiol on cyp450 activity and transporter mrna expression in type 2 diabetic rats","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.biopha.2025.118665_bib22","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1021\/acs.jafc.1c03105","article-title":"Regulation on citrate influx and metabolism through inhibiting slc13a5 and acly: a novel mechanism mediating the therapeutic effects of curcumin on nafld","volume":"69","author":"Sun","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118665_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41401-020-00535-x","article-title":"Tanshinone iia prevents lps-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2025.118665_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.biopha.2025.118665_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1124\/dmd.123.001449","article-title":"Bempedoic acid unveils therapeutic potential in non-alcoholic fatty liver disease: suppression of the hepatic pxr-slc13a5\/acly signaling axis","volume":"51","author":"Sun","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.biopha.2025.118665_bib26","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/liv.15967","article-title":"Crosstalk in extrahepatic and hepatic system in nafld\/nash","volume":"44","author":"Duan","year":"2024","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.biopha.2025.118665_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/pharmrev.120.000071","article-title":"Ontogeny of hepatic transporters and drug-metabolizing enzymes in humans and in nonclinical species","volume":"73","author":"van Groen","year":"2021","journal-title":"Pharm. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2025.118665_bib28","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/ptr.7589","article-title":"Pharmacokinetic of berberine, the main constituent of berberis vulgaris l.: a comprehensive review","volume":"36","author":"Khoshandam","year":"2022","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118665_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ptr.6504","article-title":"Palmatine: a review of pharmacological properties and pharmacokinetics","volume":"34","author":"Tarabasz","year":"2020","journal-title":"Phytother. Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118665_bib30","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/ptr.6117","article-title":"Inhibitory and inductive effects of corydalis saxicola bunting total alkaloids (csbta) on cytochrome p450s in rats","volume":"32","author":"Yu","year":"2018","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118665_bib31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ptr.3475","article-title":"In vitro inhibition of huanglian [rhizoma coptidis (l.)] and its six active alkaloids on six cytochrome p450 isoforms in human liver microsomes","volume":"25","author":"Han","year":"2011","journal-title":"Phytother Res."},{"key":"10.1016\/j.biopha.2025.118665_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jare.2021.10.004","article-title":"Gut microbiota and host cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: effects vary from drug to drug","volume":"39","author":"Guo","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2025.118665_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharm. Res."},{"issue":"13","key":"10.1016\/j.biopha.2025.118665_bib34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: pxr and car","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118665_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.122.000858","article-title":"Regulation of nuclear receptors pxr and car by small molecules and signal crosstalk: roles in drug metabolism and beyond","volume":"51","author":"Poudel","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2025.118665_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tox.2018.08.007","article-title":"Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease","volume":"410","author":"Li","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2025.118665_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101119","article-title":"Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease","volume":"50","author":"Xiao","year":"2021","journal-title":"Mol. Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:38:24Z","timestamp":1775781504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"alternative-id":["S0753332225008595"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118665","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated pharmacokinetic properties and tissue distribution of Corydalis saxicola Bunting total alkaloids in HFHCD-induced mice: Implications for pharmacokinetic variability in MASH treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118665"}}